Of the 29 candidate compounds tested, EE02 showed remarkable inhibition of the growth of tumor cells with high expression of EGFR and Eps8 and promoted apoptosis, while did not significantly inhibit and promote apoptosis in normal cell lines (Fig. 1, Fig. 2 and Fig. 3). The gene discussed is EGFR; the disease is neoplasm.